vs
Klaviyo, Inc.（KVYO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Klaviyo, Inc.的1.8倍（$622.0M vs $350.2M），Royalty Pharma plc净利率更高（34.4% vs 2.0%，领先32.4%），Klaviyo, Inc.同比增速更快（29.6% vs 4.8%），过去两年Klaviyo, Inc.的营收复合增速更高（29.1% vs 4.6%）
Klaviyo是一家美国科技企业，专注于提供营销自动化平台服务，核心应用场景涵盖邮件营销与短信营销，能够帮助不同规模的品牌商家高效触达用户，提升营销转化效果，现已服务全球众多电商及零售领域客户。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KVYO vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$350.2M
营收增速更快
KVYO
高出24.8%
4.8%
净利率更高
RPRX
高出32.4%
2.0%
两年增速更快
KVYO
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $350.2M | $622.0M |
| 净利润 | $7.0M | $214.2M |
| 毛利率 | 72.2% | — |
| 营业利润率 | -0.5% | 62.4% |
| 净利率 | 2.0% | 34.4% |
| 营收同比 | 29.6% | 4.8% |
| 净利润同比 | 126.1% | 2.9% |
| 每股收益（稀释后） | $0.03 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KVYORPRX
| Q4 25 | $350.2M | $622.0M | ||
| Q3 25 | $310.9M | $609.3M | ||
| Q2 25 | $293.1M | $578.7M | ||
| Q1 25 | $279.8M | $568.2M | ||
| Q4 24 | $270.2M | $593.6M | ||
| Q3 24 | $235.1M | $564.7M | ||
| Q2 24 | $222.2M | $537.3M | ||
| Q1 24 | $210.0M | $568.0M |
净利润KVYORPRX
| Q4 25 | $7.0M | $214.2M | ||
| Q3 25 | $-426.0K | $288.2M | ||
| Q2 25 | $-24.3M | $30.2M | ||
| Q1 25 | $-14.1M | $238.3M | ||
| Q4 24 | $-27.0M | $208.2M | ||
| Q3 24 | $-1.3M | $544.0M | ||
| Q2 24 | $-4.9M | $102.0M | ||
| Q1 24 | $-12.9M | $4.8M |
毛利率KVYORPRX
| Q4 25 | 72.2% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 75.7% | — | ||
| Q1 25 | 75.8% | — | ||
| Q4 24 | 73.4% | — | ||
| Q3 24 | 76.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 78.6% | — |
营业利润率KVYORPRX
| Q4 25 | -0.5% | 62.4% | ||
| Q3 25 | -3.5% | 70.1% | ||
| Q2 25 | -10.7% | 36.3% | ||
| Q1 25 | -8.5% | 94.0% | ||
| Q4 24 | -12.8% | 60.9% | ||
| Q3 24 | -5.6% | — | ||
| Q2 24 | -6.3% | 50.2% | ||
| Q1 24 | -10.5% | -13.0% |
净利率KVYORPRX
| Q4 25 | 2.0% | 34.4% | ||
| Q3 25 | -0.1% | 47.3% | ||
| Q2 25 | -8.3% | 5.2% | ||
| Q1 25 | -5.0% | 41.9% | ||
| Q4 24 | -10.0% | 35.1% | ||
| Q3 24 | -0.6% | 96.3% | ||
| Q2 24 | -2.2% | 19.0% | ||
| Q1 24 | -6.1% | 0.8% |
每股收益（稀释后）KVYORPRX
| Q4 25 | $0.03 | $0.49 | ||
| Q3 25 | $0.00 | $0.67 | ||
| Q2 25 | $-0.09 | $0.07 | ||
| Q1 25 | $-0.05 | $0.55 | ||
| Q4 24 | $-0.09 | $0.46 | ||
| Q3 24 | $-0.01 | $1.21 | ||
| Q2 24 | $-0.02 | $0.23 | ||
| Q1 24 | $-0.05 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $1.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KVYORPRX
| Q4 25 | $1.1B | $618.7M | ||
| Q3 25 | $980.3M | $938.9M | ||
| Q2 25 | $935.5M | $631.9M | ||
| Q1 25 | $888.4M | $1.1B | ||
| Q4 24 | $881.5M | $929.0M | ||
| Q3 24 | $826.7M | $950.1M | ||
| Q2 24 | $793.6M | $1.8B | ||
| Q1 24 | $755.8M | $843.0M |
总债务KVYORPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益KVYORPRX
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.0B | $10.3B | ||
| Q3 24 | $1.0B | $10.3B | ||
| Q2 24 | $979.5M | $9.8B | ||
| Q1 24 | $937.5M | $9.9B |
总资产KVYORPRX
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.4B | $18.3B | ||
| Q1 25 | $1.3B | $17.6B | ||
| Q4 24 | $1.3B | $18.2B | ||
| Q3 24 | $1.2B | $18.0B | ||
| Q2 24 | $1.1B | $17.7B | ||
| Q1 24 | $1.1B | $16.1B |
负债/权益比KVYORPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $93.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $90.7M | — |
| 自由现金流率自由现金流/营收 | 25.9% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | 13.26× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $208.5M | — |
8季度趋势，按日历期对齐
经营现金流KVYORPRX
| Q4 25 | $93.2M | $827.1M | ||
| Q3 25 | $54.8M | $702.6M | ||
| Q2 25 | $55.7M | $364.0M | ||
| Q1 25 | $14.4M | $596.1M | ||
| Q4 24 | $60.1M | $742.5M | ||
| Q3 24 | $38.8M | $703.6M | ||
| Q2 24 | $40.9M | $658.2M | ||
| Q1 24 | $26.2M | $664.6M |
自由现金流KVYORPRX
| Q4 25 | $90.7M | — | ||
| Q3 25 | $52.5M | — | ||
| Q2 25 | $53.7M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | $57.7M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | $40.1M | — | ||
| Q1 24 | $24.9M | — |
自由现金流率KVYORPRX
| Q4 25 | 25.9% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 18.3% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | 15.8% | — | ||
| Q2 24 | 18.1% | — | ||
| Q1 24 | 11.9% | — |
资本支出强度KVYORPRX
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.6% | — |
现金转化率KVYORPRX
| Q4 25 | 13.26× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KVYO
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
